Therapeutic Advances In Medical Oncology

New frontiers in the medical management of gastrointestinal stromal tumours

Salvage surgery for recurrent or persistent tumour after radical (chemo)radiotherapy for locally advanced non-small cell lung cancer: a systematic review

Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?

The endonuclease APE1 processes miR-92b formation, thereby regulating expression of the tumor suppressor LDLR in cervical cancer cells

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer

Inhibitors targeting CDK4/ PARP and PI3K in breast cancer: a review

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives

Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma

Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment

Academic oncology clinicians' understanding of biosimilars and information needed before prescribing